These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Methodological approach to inter "guideline" variability in the management of bipolar disorders]. Samalin L; Llorca PM Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270 [TBL] [Abstract][Full Text] [Related]
23. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related]
24. Treatment implications of predominant polarity and the polarity index: a comprehensive review. Carvalho AF; Quevedo J; McIntyre RS; Soeiro-de-Souza MG; Fountoulakis KN; Berk M; Hyphantis TN; Vieta E Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25522415 [TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Srivastava S; Ketter TA Clin Ther; 2011 Dec; 33(12):B40-8. PubMed ID: 22177379 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of adjunctive antidepressant treatment for bipolar depression. Sachs GS; Nierenberg AA; Calabrese JR; Marangell LB; Wisniewski SR; Gyulai L; Friedman ES; Bowden CL; Fossey MD; Ostacher MJ; Ketter TA; Patel J; Hauser P; Rapport D; Martinez JM; Allen MH; Miklowitz DJ; Otto MW; Dennehy EB; Thase ME N Engl J Med; 2007 Apr; 356(17):1711-22. PubMed ID: 17392295 [TBL] [Abstract][Full Text] [Related]
27. Clinical and therapeutic implications of predominant polarity in bipolar disorder. Colom F; Vieta E; Daban C; Pacchiarotti I; Sánchez-Moreno J J Affect Disord; 2006 Jul; 93(1-3):13-7. PubMed ID: 16650901 [TBL] [Abstract][Full Text] [Related]
29. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
30. Treatment options for acute depression in bipolar disorder. Bauer M; Ritter P; Grunze H; Pfennig A Bipolar Disord; 2012 May; 14 Suppl 2():37-50. PubMed ID: 22510035 [TBL] [Abstract][Full Text] [Related]
31. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
32. Lamotrigine: a depression mood stabiliser. Herman E Eur Neuropsychopharmacol; 2004 May; 14 Suppl 2():S89-93. PubMed ID: 15142613 [TBL] [Abstract][Full Text] [Related]
33. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder. Popovic D; Reinares M; Amann B; Salamero M; Vieta E Psychopharmacology (Berl); 2011 Feb; 213(4):657-67. PubMed ID: 21052983 [TBL] [Abstract][Full Text] [Related]
34. Acute and maintenance treatment with mood stabilizers. Bowden CL Int J Neuropsychopharmacol; 2003 Sep; 6(3):269-75. PubMed ID: 12974993 [TBL] [Abstract][Full Text] [Related]
35. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Vieta E; Günther O; Locklear J; Ekman M; Miltenburger C; Chatterton ML; Åström M; Paulsson B Int J Neuropsychopharmacol; 2011 Sep; 14(8):1029-49. PubMed ID: 21733231 [TBL] [Abstract][Full Text] [Related]
36. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Muzina DJ; Calabrese JR Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919 [TBL] [Abstract][Full Text] [Related]
37. Treatment options for bipolar depression: a systematic review of randomized, controlled trials. Vieta E; Locklear J; Günther O; Ekman M; Miltenburger C; Chatterton ML; Aström M; Paulsson B J Clin Psychopharmacol; 2010 Oct; 30(5):579-90. PubMed ID: 20814319 [TBL] [Abstract][Full Text] [Related]
38. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. Grunze H; Vieta E; Goodwin GM; Bowden C; Licht RW; Möller HJ; Kasper S; World J Biol Psychiatry; 2013 Apr; 14(3):154-219. PubMed ID: 23480132 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials. Beynon S; Soares-Weiser K; Woolacott N; Duffy S; Geddes JR J Psychopharmacol; 2009 Jul; 23(5):574-91. PubMed ID: 18635701 [TBL] [Abstract][Full Text] [Related]
40. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Cipriani A; Barbui C; Salanti G; Rendell J; Brown R; Stockton S; Purgato M; Spineli LM; Goodwin GM; Geddes JR Lancet; 2011 Oct; 378(9799):1306-15. PubMed ID: 21851976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]